Shenyang Xingqi Pharmaceutical Co. Ltd Financials

Market Capitalization CN¥14.67 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	41.86
Forward PE	19.33
Price to Sales TTM	CN¥8.14
Price to Book MRQ	CN¥8.97
Enterprise to Revenue	7.99
Enterprise to EBITDA	30.21

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	19.34%
Operating Margin	25.76%
Return on Assets TTM	11.87%
Return on Equity TTM	21.63%

Income Statement

Revenue TTM	CN¥1,801,999,232
Revenue per Share TTM	CN¥10.33
Quarterly Revenue Growth	30.50%
Gross Profit TTM	CN¥1,135,509,224
EBITDA	CN¥416,031,079
Net Income to Common TTM	CN¥348,467,392
Diluted EPS TTM	CN¥2.00
Quarterly Earnings Growth YoY	28.40%

Balance Sheet

Total Cash MRQ	CN¥503,308,320
Total Cash per Share MRQ	CN¥2.89
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	15.19
Current Ratio MRQ	1.96
Book Value per Share MRQ	CN¥9.33

Cash Flow

Operating Cash Flow TTM	CN¥447,297,376
Levered Free Cash Flow TTM	CN¥206,912,256

300573 Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	175,248,992
Float Shares	120,510,143
Avg 10 Volume	5,444,151
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	31.96%
% Held by Institutions	17.93%

Stock Price Summary

Beta	0.10
Fifty Two Week Low	CN¥64.88
Fifty Two Week High	CN¥214.36
Fifty Two Week Change	-49.13%
Day 50 MA	CN¥89.69
Day 200 MA	CN¥131.29

Dividends and Splits

Forward Annual Dividend Rate	CN¥1.00
Forward Annual Dividend Yield	1.42%
Trailing Annual Dividend Rate	CN¥3.50
Trailing Annual Dividend Yield	4.96%
Payout Ratio	150.11%
Dividend Date
Ex Dividend Date	2024-10-16
Last Split Factor
Last Split Date	2024-05-22